UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Role of Systematic Control Biopsies following Partial Gland Ablation with High-Intensity Focused Ultrasound for Clinically Significant Prostate Cancer

The Journal of urology, 2021-11, Vol.206 (5), p.1177-1183

2021

Volltextzugriff (PDF)

Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval

Frontiers in immunology, 2023-08, Vol.14, p.1260498

2023

Volltextzugriff (PDF)

The current status of gene therapy in bladder cancer

Expert review of anticancer therapy, 2023-05, Vol.23 (5), p.531-543

2023

Volltextzugriff (PDF)

Bladder-sparing protocols in the treatment of muscle-invasive bladder cancer

Translational andrology and urology, 2020-12, Vol.9 (6), p.2920-2937

2020

Volltextzugriff (PDF)

Biliary mucinous cystic neoplasm mimicking a hydatid cyst: a case report and literature review

BMC gastroenterology, 2019-06, Vol.19 (1), p.103-103, Article 103

2019

Volltextzugriff (PDF)

Global Greenlight Group: largest international Greenlight experience for benign prostatic hyperplasia to assess efficacy and safety

World journal of urology, 2021-12, Vol.39 (12), p.4389-4395

2021

Volltextzugriff (PDF)

Impact of surgical wait times during summer months on the oncological outcomes following robotic-assisted radical prostatectomy: 10 years’ experience from a large Canadian academic center

World journal of urology, 2021-08, Vol.39 (8), p.2913-2919

2021

Volltextzugriff (PDF)

Prostate cancer biochemical recurrence after salvage radiotherapy: first look into risk stratification and prognosis

BJU international, 2018-03, Vol.121 (3), p.320-321

2018

Volltextzugriff (PDF)

Detectable Prostate-specific antigen value between 0.01 and 0.1 ng/ml following robotic-assisted radical prostatectomy (RARP): does it correlate with future biochemical recurrence?

World journal of urology, 2021-06, Vol.39 (6), p.1853-1860

2021

Volltextzugriff (PDF)

MP65-06 NOVEL COMBINATION THERAPY USING INTERFERON GENE THERAPY AND GEMCITABINE IN MURINE BLADDER CANCER CELL LINES

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

MP65-05 SINGLE-CELL RNA SEQUENCING IDENTIFIES CHANGES IN TUMOR MICROENVIRONMENT INDUCED BY INTERFERON α GENE THERAPY IN MURINE BLADDER CANCER MODEL

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

Accuracy of Clarius, Handheld Wireless Point-of-Care Ultrasound, in Evaluating Prostate Morphology and Volume Compared to Radical Prostatectomy Specimen Weight: Is There a Difference between Transabdominal vs Transrectal Approach?

Journal of endourology, 2021-09, Vol.35 (9), p.1300-1306

2021

Volltextzugriff (PDF)

PD51-12 COST-EFFECTIVENESS OF IMMUNOTHERAPIES IN METASTATIC BLADDER CANCER: A CANADIAN HEALTHCARE PERSPECTIVE

The Journal of urology, 2020-04, Vol.203, p.e1088

2020

Volltextzugriff (PDF)

MP65-12 FOXF1: A NOVEL REGULATOR OF METASTASIS IN UROTHELIAL CARCINOMA OF THE BLADDER

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

Global experience and progress in GreenLight-XPS 180-Watt photoselective vaporization of the prostate

World journal of urology, 2022-06, Vol.40 (6), p.1513-1522

2022

Volltextzugriff (PDF)

Reply by Authors

The Journal of urology, 2021-11, Vol.206 (5), p.1183-1183

2021

Volltextzugriff (PDF)

NOVEL COMBINATION THERAPY USING INTERFERON GENE THERAPY AND GEMCITABINE IN MURINE BLADDER CANCER CELL LINES

Urologic oncology, 2024-03, Vol.42, p.S47-S48

2024

Volltextzugriff (PDF)

PD42-06 BOOSTING THE COMBINATION OF RADIATION AND ANTI-PD-L1 WITH STING AGONIST IN A PRECLINICAL MUSCLE INVASIVE BLADDER CANCER MURINE MODEL

The Journal of urology, 2021-09, Vol.206 (Supplement 3)

2021

Volltextzugriff (PDF)

PD17-12 ONCOLOGICAL OUTCOMES OF FOCAL HIGH-INTENSITY FOCUSED ULTRASOUND FOR INTERMEDIATE RISK PROSTATE CANCER TREATMENT: A FIRST NORTH AMERICAN EXPERIENCE WITH FOCAL ONE

The Journal of urology, 2020-04, Vol.203 (Supplement 4)

2020

Volltextzugriff (PDF)

FOXF1: A NOVEL REGULATOR OF METASTASIS IN UROTHELIAL CARCINOMA OF THE BLADDER

Urologic oncology, 2024-03, Vol.42, p.S27-S27

2024

Volltextzugriff (PDF)

Predictors of deviation in neurovascular bundle preservation during robotic prostatectomy

Canadian journal of urology, 2019-02, Vol.26 (1), p.9644

2019

Volltextzugriff (PDF)

180W-LBO GreenLight XPS laser vaporization for benign prostatic hyperplasia: our experience with current markers of surgical proficiency for durable and reproducible outcomes

Canadian journal of urology, 2017-08, Vol.24 (4), p.8922

2017

Volltextzugriff (PDF)

Optimizing Sequence of PD-L1 Immune-Checkpoint Inhibitors and Radiation Therapy in Bladder Cancer

Bladder cancer, 2020-01, Vol.6 (3), p.295-302

2020

Volltextzugriff (PDF)

Safety, Perioperative, and Early Functional Outcomes of Vapor Incision Technique Using the GreenLight XPS 180 W System: Direct Comparison with Photoselective Vaporization of the Prostate

Journal of endourology, 2017-01, Vol.31 (1), p.43-49

2017

Volltextzugriff (PDF)

MP05-10 UPDATE ON THE LARGEST CANADIAN RARP EXPERIENCE: ONCOLOGICAL AND FUNCTIONAL OUTCOMES OF 1034 RARP CASES WITH 6-YEAR FOLLOW-UP

The Journal of urology, 2018-04, Vol.199 (4), p.e46-e46

2018

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(48)
Buchkapitel
(1)

Sprache

Englisch
(49)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Role of Systematic Control Biopsies following Partial Gland Ablation with High-Intensity Focused Ultrasound for Clinically Significant Prostate Cancer

Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval

The current status of gene therapy in bladder cancer

Bladder-sparing protocols in the treatment of muscle-invasive bladder cancer

Biliary mucinous cystic neoplasm mimicking a hydatid cyst: a case report and literature review

Global Greenlight Group: largest international Greenlight experience for benign prostatic hyperplasia to assess efficacy and safety

Impact of surgical wait times during summer months on the oncological outcomes following robotic-assisted radical prostatectomy: 10 years’ experience from a large Canadian academic center

Prostate cancer biochemical recurrence after salvage radiotherapy: first look into risk stratification and prognosis

Detectable Prostate-specific antigen value between 0.01 and 0.1 ng/ml following robotic-assisted radical prostatectomy (RARP): does it correlate with future biochemical recurrence?

MP65-06 NOVEL COMBINATION THERAPY USING INTERFERON GENE THERAPY AND GEMCITABINE IN MURINE BLADDER CANCER CELL LINES

MP65-05 SINGLE-CELL RNA SEQUENCING IDENTIFIES CHANGES IN TUMOR MICROENVIRONMENT INDUCED BY INTERFERON α GENE THERAPY IN MURINE BLADDER CANCER MODEL

Accuracy of Clarius, Handheld Wireless Point-of-Care Ultrasound, in Evaluating Prostate Morphology and Volume Compared to Radical Prostatectomy Specimen Weight: Is There a Difference between Transabdominal vs Transrectal Approach?

PD51-12 COST-EFFECTIVENESS OF IMMUNOTHERAPIES IN METASTATIC BLADDER CANCER: A CANADIAN HEALTHCARE PERSPECTIVE

MP65-12 FOXF1: A NOVEL REGULATOR OF METASTASIS IN UROTHELIAL CARCINOMA OF THE BLADDER

Global experience and progress in GreenLight-XPS 180-Watt photoselective vaporization of the prostate

Reply by Authors

NOVEL COMBINATION THERAPY USING INTERFERON GENE THERAPY AND GEMCITABINE IN MURINE BLADDER CANCER CELL LINES

PD42-06 BOOSTING THE COMBINATION OF RADIATION AND ANTI-PD-L1 WITH STING AGONIST IN A PRECLINICAL MUSCLE INVASIVE BLADDER CANCER MURINE MODEL

PD17-12 ONCOLOGICAL OUTCOMES OF FOCAL HIGH-INTENSITY FOCUSED ULTRASOUND FOR INTERMEDIATE RISK PROSTATE CANCER TREATMENT: A FIRST NORTH AMERICAN EXPERIENCE WITH FOCAL ONE

FOXF1: A NOVEL REGULATOR OF METASTASIS IN UROTHELIAL CARCINOMA OF THE BLADDER

Predictors of deviation in neurovascular bundle preservation during robotic prostatectomy

180W-LBO GreenLight XPS laser vaporization for benign prostatic hyperplasia: our experience with current markers of surgical proficiency for durable and reproducible outcomes

Optimizing Sequence of PD-L1 Immune-Checkpoint Inhibitors and Radiation Therapy in Bladder Cancer

Safety, Perioperative, and Early Functional Outcomes of Vapor Incision Technique Using the GreenLight XPS 180 W System: Direct Comparison with Photoselective Vaporization of the Prostate

MP05-10 UPDATE ON THE LARGEST CANADIAN RARP EXPERIENCE: ONCOLOGICAL AND FUNCTIONAL OUTCOMES OF 1034 RARP CASES WITH 6-YEAR FOLLOW-UP

Suchergebnisse filtern